Navigation Links
The Best Radiation Therapy Solution just got Better
Date:7/18/2012

SUNNYVALE, Calif., July 18, 2012 /PRNewswire/ -- IntraOp Medical Corporation (OTC: IOPD.PK - News) installed the 10th of the next generation Mobetrons last week at Helios-Kliniken (helios-kliniken.de) in Berlin Germany.  The Mobetron is used for electron IORT (IOERT), which has demonstrated the best overall clinical results of any breast cancer treatment, resulting in 10 year recurrence rates as low as 1%.  Currently each Mobetron in Germany treats between 250-350 breast cancer patients per year with IOERT. Many of these patients are also eligible for oncoplastic reconstruction which eliminates the need for additional cosmetic surgery and speeds the process of "emotional reconstruction".  Germany is a leader of evidence based medicine.  The rapid adoption of IOERT for breast cancer treatment is immediately allowing thousands of women with breast cancer to achieve better results and cosmesis, over a shorter treatment course.  IOERT provides the treatment flexibility to accommodate nearly all breast patients including younger pre-menopausal patients.

"IOERT is becoming the gold standard in the successful treatment of cancer," says Ernesto G. Lanzotti, Director of MD51 Germany GmbH, IntraOp Medical European distributor.  "We are very proud to start cooperating with Helios Kliniken because we understand the importance from both a treatment and medical science aspect and Helios-Kliniken is a leader in this regard."

The next generation Mobetron has also added a new benefit to the environment as well.  The Mobetron provides radiation therapy (RT) more efficiently than any other RT technique, using less time, less energy, and producing little to no waste.  The Mobetron can deliver a complete course of radiation therapy for select breast cancer candidates in 2 minutes using less than one tenth of a kilowatt hour (kWh) of electricity.  The same treatment using conventional external beam radiation therapy requires 90 minutes of treatment (beam) over 30 days and uses over 100 kWh's for treatment and cooling.

The Mobetron is a true linear accelerator and generates only the radiation it needs for a given treatment without having to use active radioactive radiation sources.  The Mobetron does not use disposable applicators like some of the other methods to treat cancers Intra-Operatively.  This is effective for reducing both cost and waste.  The Healthcare industry is the second largest producer of waste behind the food service industry and this will continue to be an area of great attention.  "Eventually, policy will be enacted to discourage waste as seen in other industries, and we want to help lead this initiative," said John Powers, IntraOp Medical's CEO.  For these reasons it is no surprise that the Mobetron is gaining more attention worldwide with Mobetrons recently shipping to new markets in Saudi Arabia and Turkey.

About IntraOp

IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer IOERT safely and effectively for all cancer patients. The Mobetron is the first IOERT device designed for use in existing operating rooms and has been used to treat over 20 different cancer indications. Mobetron benefits include: increased survival rates, better local tumor control, shorter treatment cycles, and happier patients with fewer side effects. Leading hospitals and clinics throughout the world use the Mobetron as a vital part of their comprehensive cancer program. For more information email info@intraopmedical.com or call 408-636-1020 x128.

About Helios

The HELIOS Hospital Group ranks among the largest and most medically advanced hospital groups in Germany. Since 2005 HELIOS is part of the global healthcare provider Fresenius Fresenius SE & Co.KGaA.

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of Section 27A of the 1933 Securities Act and Section 21E of the 1934 Securities Exchange Act. By making these forward-looking statements, the Company can give no assurances that transactions described in this press release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.


'/>"/>
SOURCE IntraOp Medical Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Radiation Therapy in Oncology Drug Pipeline Update 2012
2. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
3. ViewRay Receives FDA 510(k) Clearance for MRI-Guided Radiation Therapy System
4. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
5. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
6. Fujitsu to Showcase Radiation-Hardened RFID Using FRAM Technology at Interphex 2012 in New York City, Booth #2430
7. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
8. Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
9. United States Market for Psoriatic Arthritis Pharmacotherapy
10. Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
11. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... -- This TforG report includes the Surgical Procedures Database ... system in South Korea . To ... provides written and numerical analysis on the current trends, ... the latest reforms of the local Healthcare system are ... The report helps businesses gain a unique insight ...
(Date:2/9/2016)... , Feb. 9, 2016  Johnson & Johnson ... Capital Markets Global Healthcare Conference on Tuesday, Feb. 23, ... Dominic Caruso , Vice President, Finance & Chief ... Consumer will represent the Company in a session scheduled ... . --> www.investor.jnj.com . --> ...
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week ... series of monitor mounts ever. , “Our goal was to develop a product ... install system that we have ever created.” said Darren Hulsey, Product Manager for Workrite ...
(Date:2/10/2016)... ... February 09, 2016 , ... A new leadership team for Mid-South Youth Camp, ... Wiley made the announcement Monday night, Feb. 8, prior to the evening session of ... and the creator of GO! Camp, has been named director. Gayle McDonald, currently the ...
(Date:2/10/2016)... (PRWEB) , ... February 09, 2016 , ... ... sports concussion, yet the cause of injury may be one of many possible ... advanced PT Continuing Education Course , Mastering Rehab Solutions for the ...
(Date:2/9/2016)... ... February 09, 2016 , ... Interstate Restoration LLC, a ... announced today the acquisition of Hawaii DKI. Hawaii DKI is one of the ... like-minded companies who excel at service and response helps support our goal of ...
(Date:2/9/2016)... ... February 09, 2016 , ... Cirracore Enterprise Cloud, ... move workloads to the cloud. Cirracore provides a secure VMware® vCloud Air ... the Internet. Transformation Solutions (TSL Partners) provides a full range of services ...
Breaking Medicine News(10 mins):